# Forxiga Tablets Specific Clinical Experience Investigation for Long-term Use

> **NCT02200666** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 7793 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02200666
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10-03
- **Primary completion:** 2019-09-09
- **Final completion:** 2019-09-09
- **Target enrollment:** 7793 (ACTUAL)
- **Last updated:** 2020-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02200666

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02200666, "Forxiga Tablets Specific Clinical Experience Investigation for Long-term Use". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02200666. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*